Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults

American Journal of Alzheimer's Disease and other Dementias

Volumn 29, Issue 3, 2014, Pages 222-235

  Foley, Jessica M ^a,b   Salat, David H ^a,b,c   Stricker, Nikki H ^a,d   Zink, Tyler A ^a,b,d   Grande, Laura J ^a,b   McGlinchey, Regina E ^a,b   Milberg, William P ^a,b   Leritz, Elizabeth C ^a,b,c,e  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Alzheimer's disease; APOE4; diabetes; healthy aging; white matter

Indexed keywords

APOLIPOPROTEIN E4; GLUCOSE; HEMOGLOBIN A1C;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; GENOTYPE; HUMAN; IMAGE PROCESSING; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECUNEUS; PROTEIN INTERACTION; RISK; WHITE MATTER LESION; AGING; BRAIN; DEVICES; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; WHITE MATTER;

AGED; AGING; APOLIPOPROTEIN E4; CEREBRUM; DIABETES MELLITUS; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; WHITE MATTER;

EID: 84900426707     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513517045     Document Type: Article

References (112)

1. Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009 ; 11 (2). 111-128
2. Götz J, Ittner LM, Lim YA. Common features between diabetes mellitus and Alzheimer's disease. Cell Mol Life Sci. 2009 ; 66 (8). 1321-1325
3. Hämäläinen A, Grau-Olivares M, Tervo S, et al. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study. Neurodegener Dis. 2008 ; 5 (3-4). 186-189
4. Jack CR, Petersen RC, Xu Y, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998 ; 51 (4). 993-999
5. Plassman BL, Welsh-Bohmer KA, Bigler ED, et al. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology. 1997 ; 48 (4). 985-989
6. Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 1997 ; 48 (1). 139-147
7. Hsiung GY, Sadovnick AD, Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia. CMAJ. 2004 ; 171 (8). 863-867
8. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 ; 43 (8). 1467-1472
9. Cherbuin N, Leach LS, Christensen H, Anstey KJ. Neuroimaging and APOE genotype: a systematic qualitative review. Demen Geriatr Cogn Disord. 2007 ; 24 (5). 348-62
10. Reiman EM, Uecker A, Caselli RJ, et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol. 1998 ; 44 (2). 288-291
11. Jernigan TL, Archibald SL, Fennema-Notestine C, et al. Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging. 2001 ; 22 (4). 581-594
12. Morra JH, Tu Z, Apostolova LG, et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage. 2009 ; 45 (1). S3 - S15
13. Serra-Grabulosa JM, Salgado-Pineda P, Junqué C, et al. Apolipoproteins E and C1 and brain morphology in memory impaired elders. Neurogenetics. 2003 ; 4 (3). 141-146
14. Schmidt H, Schmidt R, Fazekas F, et al. Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet. 1996 ; 50 (5). 293-299
15. Tohgi H, Takahashi S, Kato E, et al. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett. 1997 ; 236 (1). 21-24
16. Convit A, de Asis J, de Leon MJ, Tarshish CY, De Santi S, Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging. 2000 ; 21 (1). 19-26
17. Burggren AC, Zeineh MM, Ekstrom AD, et al. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage. 2008 ; 41 (4). 1177-1183
18. de Leeuw FE, Richard F, de Groot JC, et al. Interaction between hypertension, apoE. Stroke. 2004 ; 35 (5). 1057-1060
19. Høgh P, Garde E, Mortensen EL, Jørgensen OS, Krabbe K, Waldemar G. The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities. Acta Neurol Scand. 2007 ; 115 (4). 248-253
20. Kim JS, Han SR, Chung SW, et al. The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease. J Neurol Sci. 2003 ; 206 (1). 31-37
21. Liu Y, Laakso MP, Karonen JO, et al. Apolipoprotein E polymorphism and acute ischemic stroke: a diffusion- and perfusion-weighted magnetic resonance imaging study. J Cereb Blood Flow Metab. 2002 ; 22 (11). 1336-1342
22. Nierenberg J, Pomara N, Hoptman MJ, Sidtis JJ, Ardekani BA, Lim KO. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. Neuroreport. 2005 ; 16 (12). 1369-1372
23. Tesseur I, Van Dorpe J, Bruynseels K, et al. Prominent axonopathy and disruption of axonal. Am J Pathol. 2000 ; 157 (5). 1495-1510
24. Wen HM, Baum L, Cheung WS, et al. Apolipoprotein E epsilon4 allele is associated with the volume of white matter changes in patients with lacunar infarcts. Eur J Neurol. 2006 ; 13 (11). 1216-1220
25. Raz N, Rodrigue KM. Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci Biobehav Rev. 2006 ; 30 (6). 730-748
26. Kennedy KM, Raz N. Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk. Brain Res. 2009 ; 1297: 41-56
27. Leritz EC, Salat DH, Milberg WP, et al. Variation in blood pressure is associated with white matter microstructure but not cognition in African Americans. Neuropsychology. 2010 ; 24 (2). 199-208
28. Leritz EC, Salat DH, Williams VJ, et al. Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults. Neuroimage. 2011 ; 54 (4). 2659-2671
29. Salat DH, Williams VJ, Leritz EC, et al. Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults. Neuroimage. 2012 ; 59 (1). 181-192
30. Williams VJ, Leritz EC, Shepel J, et al. Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Hum Brain Mapp. 2013 ; 34 (8). 1826-1841
31. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res. 2010 ; 106 (8). 1319-1331
32. Akomolafe A, Beiser A, Meigs JB, et al. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham study. Arch Neurol. 2006 ; 63 (11). 1551-1555
33. Irie F, Fitzpatrick AL, Lopez OL, et al. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the cardiovascular health study cognition study. Arch Neurol. 2008 ; 65 (1). 89-93
34. Peila R, Rodriguez BL, Launer LJ. Honolulu-Asia Aging Study. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes. 2002 ; 51 (4). 1256-1262
35. Caselli RJ, Dueck AC, Locke DE, et al. Cerebrovascular risk factors and preclinical memory decline in healthy APOE 4 homozygotes. Neurology. 2011 ; 76 (12). 1078-1084
36. Matsuzaki T, Sasaki K, Tanizaki Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology. 2010 ; 75 (9). 764-770
37. Craft S, Asthana S, Cook DG, et al. Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: Interactions with apolipoprotein E genotype. Psychoneuroendocrinology. 2003 ; 28 (6). 809-822
38. Craft S, Asthana S, Schellenberg G, et al. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer' s disease differ according to Apolipoprotein-E genotype. Ann N Y Acad Sci. 2000 ; 903: 222-228
39. de la Torre JC. Alzheimer's disease: how does it start?. J Alzheimers Dis. 2002 ; 4 (6). 497-512
40. Burns JM, Church JA, Johnson DK, et al. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Arch Neurol. 2005 ; 62 (12). 1870-1876
41. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet. 1999 ; 354 (9182). 919-920
42. Gold BT, Johnson NF, Powell DK, Smith CD. White matter integrity and vulnerability to Alzheimer. Biochim Biophys Acta. 2012 ; 1822 (3). 416-422
43. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E. Impact of white matter changes on clinical manifestation of Alzheimer's disease: a quantitative study. Stroke. 2000 ; 31 (9). 2182-2188
44. Sjöbeck M, Englund E. Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes. Neuropathol Appl Neurobiol. 2003 ; 29 (2). 159-169
45. Bartzokis G.. Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging. 2004 ; 25 (1). 5-18
46. Bartzokis G, Lu PH New Encyclopedia of Neuroscience. Squire LR, ed. Oxford: Academic Press ; 2007: 417-427.
47. Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL. Cummings, Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry. 2006 ; 63 (1). 63-72
48. Bartzokis G, Lu PH, Geschwind DH, et al. Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol Psychiatry. 2007 ; 62 (12). 1380-1387
49. Bartzokis G, Lu PH, Mintz J. Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement. 2007 ; 3 (2). 122-125
50. Lenroot RK, Giedd JN. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci Biobehav Rev. 2006 ; 30 (6). 718-729
51. Hsu JL, Chen YL, Leu JG, et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: A diffusion tensor imaging study. Neuroimage. 2012 ; 59 (2). 1098-1105
52. Reisberg B, Franssen EH, Hasan SM, et al. Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes. Eur Arch Psychiatry Clin Neurosci. 1999 ; 249 (suppl 3). 28-36
53. Yau PL, Javier D, Tsui W, et al. Emotional and neural declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes. Psychiatry Res. 2009 ; 174 (3). 223-230
54. Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed. 1995 ; 8 (7-8). 333-344
55. Sen PN, Basser PJ. A model for diffusion in white matter in the brain. Biophys J. 2005 ; 89 (5). 2927-2938
56. Bronge L. Magnetic resonance imaging in dementia. A study of brain white matter changes. Acta Radiol Suppl. 2002 ; (428). 1-32
57. Schiavone F, Charlton RA, Barrick TR, Morris RG, Markus HS. Imaging age-related cognitive decline: a comparison of diffusion tensor and magnetization transfer MRI. J Magn Reson Imaging. 2009 ; 29 (1). 23-30
58. Sjöbeck M, Elfgren C, Larsson EM, et al. Alzheimer's disease (AD) and executive dysfunction. A case-control study on the significance of frontal white matter changes detected by diffusion tensor imaging (DTI). Arch Gerontol Geriatr. 2010 ; 50 (3). 260-266
59. Ukmar M, Makuc E, Onor ML, Garbin G, Trevisiol M, Cova MA. Evaluation of white matter damage in patients with Alzheimer's disease and in patients with mild cognitive impairment by using diffusion tensor imaging. Radiol Med. 2008 ; 113 (6). 915-922
60. Salat DH, Tuch DS, Hevelone ND, et al. Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann N Y Acad Sci. 2005 ; 1064: 37-49
61. Salat DH, Tuch DS, van der Kouwe AJ, et al. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging. 2010 ; 31 (2). 244-256
62. Bendlin BB, Ries ML, Canu E, et al. White matter is altered with parental family history of Alzheimer's disease. Alzheimers Dement. 2010 ; 6 (5). 394-403
63. Honea RA, Vidoni E, Harsha A, Burns JM. Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis. 2009 ; 18 (3). 553-564
64. Kanchibhotla SC, Mather KA, Wen W, Schofield PR, Kwok JB, Sachdev PS. Genetics of ageing-related changes in brain white matter integrity: a review. Ageing Res Rev. 2013 ; 12 (1). 391-401
65. Persson J, Nyberg L, Lind J, et al. Structure-function correlates of cognitive decline in aging. Cereb Cortex. 2006 ; 16 (7). 907-915
66. Westlye ET, Hodneland E, Haász J, Espeseth T, Lundervold A, Lundervold AJ. Episodic memory of APOE 4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe. Neuroimage. 2012 ; 63 (1). 507-516
67. Leritz EC, Shepel J, Williams VJ, et al. Associations between T(1) white matter lesion volume and regional white matter microstructure in aging [published online January 30, 2013]. Hum Brain Mapp. 2013 ;:
68. Fortuny LA, Briggs M, Newcombe F, Ratcliff G, Thomas C. Thomas, measuring the duration of post traumatic amnesia. J Neurol Neurosurg Psychiatry. 1980 ; 43 (5). 377-379
69. Bohnstedt M, Fox PJ, Kohatsu ND. Correlates of mini-mental status examination scores among elderly demented patients: the influence of race-ethnicity. J Clin Epidemiol. 1994 ; 47 (12). 1381-1387
70. A2009,.
71. Reese TG, Heid O, Weisskoff RM, Wedeen VJ. Reduction of eddy-current-induced distortion in diffusion MRI using a twice-refocused spin echo. Magn Reson Med. 2003 ; 49 (1). 177-182
72. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004 ; 23 (suppl 1). S208 - S219
73. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006 ; 31 (4). 1487-1505
74. AnderssonJLRJenkinsonMSmithS. Non-linear optimisation. FMRIB technical report TR07JA1 fromwww.fmrib.ox.ac.uk/analysis/techrep. 2007Accessed March 2013.
75. AnderssonJLRJenkinsonMSmithS. Non-linear registration, aka spatial normalisation FMRIB technical report TR07JA2 fromwww.fmrib.ox.ac.uk/analysis/ techrep. 2007Accessed March 2013.
76. Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach MO, Hawkes DJ. Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging. 1999 ; 18 (8). 712-721
77. Salat DH, Greve DN, Pacheco JL, et al. Regional white matter volume differences in nondemented aging and Alzheimer's disease. Neuroimage. 2009 ; 44 (4). 1247-1258
78. Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006 ; 31 (3). 968-980
79. Greve DN, Fischl B. Fischl, accurate and robust brain image alignment using boundary-based registration. Neuroimage. 2009 ; 48 (1). 63-72
80. Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A. 2004 ; 101 (21). 8174-8179
81. Qiu D, Tan LH, Zhou K, Khong PL. Diffusion tensor imaging of normal white matter maturation from late childhood to young adulthood: Voxel-wise evaluation of mean diffusivity, fractional anisotropy, radial and axial diffusivities, and correlation with reading development. Neuroimage. 2008 ; 41 (2). 223-232
82. Lebel C, Gee M, Camicioli R, Wieler M, Martin W, Beaulieu C. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage. 2012 ; 60 (1). 340-352
83. Schneider JF, Il'yasov KA, Hennig J, Martin E. Fast quantitative diffusion-tensor imaging of cerebral white matter from the neonatal period to adolescence. Neuroradiology. 2004 ; 46 (4). 258-266
84. Partridge SC, Mukherjee P, Henry RG, et al. Diffusion tensor imaging: serial quantitation of white matter tract maturity in premature newborns. Neuroimage. 2004 ; 22 (3). 1302-1314
85. Huang W, Qiu C, von Strauss E, Winblad B, Fratiglioni L. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Arch Neurol. 2004 ; 61 (12). 1930-1934
86. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2011 ; 154 (7). 635-641
87. Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002 ; 137 (3). 149-155
88. Thambisetty M, Beason-Held L, An Y, Kraut MA, Resnick SM. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch Neurol. 2010 ; 67 (1). 93-98
89. Espeland MA, Bryan RN, Goveas JS, et al. Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the women's health initiative magnetic resonance imaging studies. Diabetes Care. 2013 ; 36 (1). 90-97
90. Jongen C, van der Grond J, Kappelle LJ, et al. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia. 2007 ; 50 (7). 1509-1516
91. Manschot SM, Brands AM, van der Grond J, et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006 ; 55 (4). 1106-1113
92. Reijmer YD, van den Berg E, de Bresser J, et al. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Diabetes Metab Res Rev. 2011 ; 27 (2). 195-202
93. Seo SW, Lee JM, Im K, et al. Cardiovascular risk factors cause cortical thinning in cognitively impaired patients: Relationships among cardiovascular risk factors, white matter hyperintensities, and cortical atrophy. Alzheimers Dis Assoc Disord. 2012 ; 26 (2). 106-112
94. Chen Z, Li L, Sun J, Ma L. Mapping the brain in type II diabetes: voxel-based morphometry using DARTEL. Eur J Radiol. 2012 ; 81 (8). 1870-1876
95. Last D, Alsop DC, Abduljalil AM, et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care. 2007 ; 30 (5). 1193-1199
96. Yau PL, Javier DC, Ryan CM, et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia. 2010 ; 53 (11). 2298-2306
97. Ryan L, Walther K, Bendlin BB, Lue LF, Walker DG, Glisky EL. Age-related differences in white matter integrity and cognitive function are related to APOE status. Neuroimage. 2011 ; 54 (2). 1565-1577
98. Hermoye L, Saint-Martin C, Cosnard G, et al. Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood. Neuroimage. 2006 ; 29 (2). 493-504
99. Paus T, Collins DL, Evans AC, Leonard G, Pike B, Zijdenbos A. Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res Bull. 2001 ; 54 (3). 255-266
100. Serlin Y, Levy J, Shalev H. Vascular pathology and blood brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus. Cardiovasc Psychiatry Neurol. 2011 ; 2011: 609202
101. Zlokovic BV. New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics. 2009 ; 5 (3). 409-414
102. Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2003 ; 74 (1). 70-76
103. Zipser BD, Johanson CE, Gonzalez L, et al. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging. 2007 ; 28 (7). 977-986
104. Nishitsuji K, Hosono T, Nakamura T, Bu G, Michikawa M. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem. 2011 ; 286 (20). 17536-17542
105. DeCarli C, Reed BR, Jagust W, Martinez O, Ortega M, Mungas D. Brain behavior relationships among African Americans, whites, and hispanics. Alzheimer's disease and associated disorders. 2008 ; 22 (4). 382-391
106. He J, Farias S, Martinez O, Reed B, Mungas D, Decarli C. Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol. 2009 ; 66 (11). 1393-1399
107. Brickman AM, Schupf N, Manly JJ, et al. Brain morphology in older African Americans, Caribbean Hispanics, and Whites from Northern Manhattan. Arch Neurol. 2008 ; 65 (8). 1053-1061
108. Okonkwo OC, Alosco ML, Jerskey BA, et al. Cerebral atrophy, apolipoprotein E4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment. Alzheimers Dement. 2010 ; 6 (5). 404-411
109. Cherbuin N, Anstey KJ, Sachdev PS, et al. Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals. J Gerontol A Biol Sci Med Sci. 2008 ; 63 (5). 501-504
110. Hashimoto M, Yasuda M, Tanimukai S, et al. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology. 2001 ; 57 (8). 1461-1466
111. Mori E, Lee K, Yasuda M, et al. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. Ann Neurol. 2002 ; 51 (2). 209-214
112. Stewart R, Russ C, Richards M, Brayne C, Lovestone S, Mann A. Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dement Geriatr Cogn Disord. 2001 ; 12 (4). 251-256